Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 21

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 21
---
 by reference to Exhibit 3.2 to the Registration Statement on Form S-1 filed with the SEC on August 30, 2018).                                                                       |
|:--------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3     |     | First Amendment to the Bylaws of INmune Bio Inc. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 23, 2024).                              |
| 5.1     |     | Opinion of Sichenzia Ross Ference Carmel LLP*                                                                                                                                                            |
| 23.1    |     | Consent of Marcum LLP*                                                                                                                                                                                   |
| 23.2    |     | Consent of Sichenzia Ross Ference Carmel LLP (included in Exhibit 5.1)*                                                                                                                                  |
| 24.1    |     | Power of Attorney (included on the signature page)*                                                                                                                                                      |
| 99.1    |     | INmune Bio Inc. Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on June 10, 2025). |
| 107     |     | Filing Fee Table*                                                                                                                                                                                        |

| * | Filed    
 herewith |

Item 9. Undertakings.

| (a) | The Company hereby undertakes: |

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act. |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered  would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no